secwatch.observer — SEC 8-K summary
======================================

Issuer:     Valion Bio, Inc. (VBIO)
CIK:        0001787740
Form:       8-K
Filed at:   2026-06-03T13:00:15+00:00
Accession:  0001683168-26-004481
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Valion Bio shareholders approve 2.58M share increase to 2021 equity plan; Dean Zikria re-elected
--------------------------------------------------------------------------------

- Shareholders approved a 2,581,608 share increase under the 2021 Equity Incentive Plan (736,919 for, 134,918 against).
- Dean Zikria was elected Class II director with 873,001 votes for and 59,543 withheld.
- Ratification of Rosenberg Rich Baker Berman as auditor for FY 2026 passed with 1,510,322 votes for.
- Proposals 4-7 (issuances to institutional investors and Tumim) approved with ~65-66% of votes cast in favor.
- Adjournment proposal approved (1,328,670 for) but not needed as all other proposals passed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787740/000168316826004481/0001683168-26-004481-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787740/000168316826004481/valion_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-004481

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer